Compare CUE & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CUE | CNVS |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.6M | 46.9M |
| IPO Year | 2018 | 2003 |
| Metric | CUE | CNVS |
|---|---|---|
| Price | $0.28 | $2.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $3.00 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 1.2M | 129.8K |
| Earning Date | 11-12-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,100,000.00 | ★ $79,791,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.00 | $30.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 77.29 |
| 52 Week Low | $0.23 | $2.03 |
| 52 Week High | $1.75 | $7.39 |
| Indicator | CUE | CNVS |
|---|---|---|
| Relative Strength Index (RSI) | 28.52 | 34.46 |
| Support Level | $0.23 | $2.07 |
| Resistance Level | $0.33 | $2.25 |
| Average True Range (ATR) | 0.05 | 0.15 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 17.05 | 13.73 |
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.